Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06232434
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-01-08
Brief Title:
An Open Prospective Randomized Clinical Study of the Effectiveness Tolerability and Safety of a Single Intraperitoneal Use of the Drug Prospidelong Powder for the Preparation of a Gel for Topical Use 1000 mg in Vials Package No 1 in Patients With Disseminated Gastric Cancer Phase I-II
Sponsor:
Research Institute for Physical Chemical Problems of the Belarusian State University
Organization:
Research Institute for Physical Chemical Problems of the Belarusian State University
Organization Data
Organization:
Research Institute for Physical Chemical Problems of the Belarusian State University
Class:
OTHER
Study ID:
ИНТЕЛОН-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Research Institute for Physical Chemical Problems of the Belarusian State University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Unitary Enterprise UNITEHPROM BSU | UNKNOWN |
| The state institution N N Alexandrov National Cancer Centre of Belarus | UNKNOWN |